Medication Denials

How to Appeal a Humira Denial: Complete Step-by-Step Guide

Appealio Team·Clinical Appeals Specialists
|January 27, 2026|8 min read

You opened the letter, or maybe it was an email, and there it was: denied. Your insurance company won't cover Humira. Your stomach dropped. Maybe you're dealing with Crohn's flares that leave you bedridden. Maybe your rheumatoid arthritis is destroying your joints while you wait. Whatever brought you here, know this: a denial is not a final answer. It's a starting point.

Humira (adalimumab), manufactured by AbbVie, is one of the most widely prescribed biologic medications in the United States. It's FDA-approved for nine conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease (adult and pediatric), Ulcerative Colitis (adult and pediatric), Plaque Psoriasis, Hidradenitis Suppurativa, Uveitis, and Juvenile Idiopathic Arthritis. Millions of patients depend on it. And yet, insurers deny it constantly.

This guide will walk you through exactly why Humira gets denied, how to build a strong appeal, and what your rights are at every step. This is educational information, not legal or medical advice. For guidance specific to your situation, consult your physician and consider speaking with a patient advocate or attorney.

Why Insurers Deny Humira

Let's be honest about what's happening. Humira is expensive, and insurance companies are in the business of managing costs. The arrival of biosimilars has given them a new tool to do exactly that.

As of now, ten Humira biosimilars have been FDA-approved in the United States. The first, Amjevita, launched in January 2023. Others include Hadlima, Hyrimoz, Cyltezo, Yuflyma, Simlandi, Hulio, Abrilada, and Yusimry. These biosimilars are clinically similar to Humira, which means insurers now have a financial reason to push patients away from the brand-name drug. Many insurers require patients to try a biosimilar before they'll cover brand Humira at all.

That doesn't mean the denial is justified. It means you need to understand the game being played so you can respond effectively.

Common Denial Reasons for Humira

Before you write a single word of your appeal, you need to identify exactly why your claim was denied. The reason matters because it determines your strategy. Look at your Explanation of Benefits (EOB) or denial letter carefully. The denial will typically fall into one of these categories:

  • Step therapy / fail-first requirements: Your insurer wants you to try a cheaper medication (often a biosimilar or a non-biologic) before approving Humira. This is the single most common reason for Humira denials.
  • Prior authorization not obtained: Your doctor prescribed Humira, but the required prior authorization wasn't submitted, was incomplete, or was denied before treatment began.
  • Biosimilar preferred: Your plan covers a Humira biosimilar but won't cover brand-name Humira. The insurer considers the biosimilar therapeutically equivalent.
  • Medical necessity not established: The insurer doesn't believe your medical records demonstrate that Humira is medically necessary for your condition.
  • Non-formulary: Humira isn't on your plan's formulary (approved drug list), or it's placed on a specialty tier with higher cost-sharing requirements.

According to KFF's 2023 analysis, ACA marketplace plans denied approximately 20% of in-network claims. But here's the critical number: consumers appealed only about 1% of those denials. Of the internal appeals that were filed, 44% succeeded. The odds are in your favor, but only if you actually appeal.

Your Right to Appeal: It's the Law

This isn't just a courtesy your insurer extends. It's a legal right. Under the Affordable Care Act (Section 2719 of the Public Health Service Act), all non-grandfathered health plans must provide you with both an internal appeal process and an external review option. That means your insurer is legally required to give you a fair chance to challenge their decision.

Internal appeals are reviewed by someone at your insurance company who wasn't involved in the original denial. If that fails, you can request an external review, where an independent third party evaluates your case. Standard external reviews are decided within 45 days. If your situation is urgent, you can request an expedited external review, which must be decided within 72 hours.

The external reviewer's decision is binding on the insurer. They have to comply. That's real leverage, and most patients never use it because they don't know it exists.

Step-by-Step: Building Your Humira Appeal

A strong appeal is built on documentation, not emotion. You might be frustrated, scared, or angry. That's understandable. But the appeal letter itself needs to be organized, specific, and backed by evidence. Here's how to do it.

Step 1: Get Your Denial Letter and Plan Documents

Start by requesting (if you don't already have) your complete denial letter, your plan's Summary of Benefits and Coverage, and the specific coverage criteria your plan uses for Humira or biologic medications. You need to know the exact reason for the denial and the exact policy language your insurer is relying on. Call the number on your insurance card and ask for these documents. They're required to provide them.

Step 2: Gather Your Medical Records

Work with your prescribing physician to compile the records that support your need for Humira. This should include your diagnosis, disease severity scores or objective measurements, a history of previous treatments you've tried (and why they didn't work), lab results, imaging, and any clinical notes documenting how your condition affects your daily life. The more specific and detailed, the better.

Step 3: Get a Letter of Medical Necessity

This is the most important document in your appeal. Ask your doctor to write a detailed letter explaining why Humira is medically necessary for your specific situation. The letter should address the insurer's denial reason directly. If they denied for step therapy, the letter should explain why the required alternative isn't appropriate for you. If they denied for medical necessity, the letter should cite specific clinical evidence.

A strong letter of medical necessity doesn't just say "this patient needs Humira." It explains exactly why, citing the patient's treatment history, disease severity, clinical guidelines, and peer-reviewed evidence. Ask your doctor to be as specific as possible.

Step 4: Write Your Appeal Letter

Your appeal letter should be clear, factual, and structured. Include your name, policy number, claim number, and the date of denial. State that you are formally appealing the denial. Then walk through your argument point by point. Reference the specific denial reason, explain why it's incorrect or doesn't apply to your situation, and cite the supporting evidence you're attaching.

Keep it professional. This letter will be read by a medical reviewer, often a nurse or physician. They're looking for clinical justification, not a personal story (though briefly mentioning the impact on your quality of life is appropriate). One to two pages is ideal for the letter itself, with supporting documents attached separately.

Step 5: Submit and Track Everything

Submit your appeal via certified mail with return receipt requested. If your insurer accepts fax submissions, send it by fax as well. Keep copies of everything: your letter, all attachments, the mailing receipt, the fax confirmation. Note the date you submitted and the deadline for the insurer's response. Follow up by phone if you haven't received a decision within the required timeframe.

Key Medical Necessity Arguments for Humira

The arguments you make will depend on your specific condition, but here are the kinds of evidence that tend to be most persuasive in Humira appeals:

  • Treatment history: Document every medication you've tried previously, including the dose, duration, and reason it was discontinued (inadequate response, side effects, contraindication). This is critical for overcoming step therapy denials.
  • Disease severity: Include objective measures like DAS28 scores (rheumatoid arthritis), CDAI or Harvey-Bradshaw Index (Crohn's), PASI scores (psoriasis), or other validated clinical tools. Numbers speak louder than adjectives.
  • Clinical guidelines: Reference treatment guidelines from organizations like the American College of Rheumatology, the American Gastroenterological Association, or the American Academy of Dermatology that support Humira for your condition and severity level.
  • Functional impact: Document how your condition affects your ability to work, care for yourself, or perform daily activities. Include specific examples.
  • Peer-reviewed literature: Attach relevant studies that support Humira's efficacy for your condition, especially if your case involves an unusual clinical scenario.

Step Therapy Override Strategies

Step therapy is the most common obstacle for Humira patients right now. Your insurer wants you to try a biosimilar or a cheaper drug first. Sometimes that's reasonable. Sometimes it's not. Here are the situations where you have strong grounds to challenge a step therapy requirement:

  • You've already tried and failed the required step therapy drug (or a clinically similar one). This is the strongest argument. If you've documented that you tried methotrexate, sulfasalazine, or a biosimilar and it didn't work or caused intolerable side effects, you've already satisfied the intent of step therapy.
  • The required drug is contraindicated for you. If you have a documented allergy, drug interaction, or medical condition that makes the step therapy drug unsafe, you can request an exception.
  • Switching would cause clinical harm. If you're already stable on Humira and your insurer wants to switch you to a biosimilar, your doctor can argue that the switch could cause disease flare, antibody development, or loss of response.
  • Your condition is urgent. If delaying treatment while you "fail first" on another drug would cause irreversible harm (joint erosion, bowel perforation, vision loss), that's grounds for an expedited exception.

Here's something many patients don't know: at least 30 states have enacted step therapy reform laws as of 2024. These laws typically require insurers to grant exceptions when a patient has already tried the required drug, when the drug is contraindicated, or when the requirement would cause irreversible harm. Check whether your state has such a law. It can significantly strengthen your appeal.

According to a 2024 American Medical Association survey, physicians handle an average of 39 prior authorizations per week. 93% report that prior authorization delays necessary care, and 29% say it has led to a serious adverse event for a patient. If your doctor seems overwhelmed by the paperwork, that's because the system is genuinely overwhelming. Be proactive in helping gather your own records.

If Your Internal Appeal Is Denied

Don't stop. A denied internal appeal is not the end. You still have the right to an external review, and this is where the playing field shifts in your favor. An independent reviewer, someone who doesn't work for your insurance company, will evaluate your case. Their decision is legally binding on the insurer.

To request an external review, follow the instructions in your internal appeal denial letter. There's usually a deadline (often 60 days from the denial), so don't wait. For your external review, strengthen your submission with any new evidence, an updated letter from your doctor, or additional clinical literature.

You can also contact your state insurance department for assistance. Many states have consumer assistance programs that can help you navigate the external review process at no cost.

Getting Help With Your Appeal

You can absolutely handle this appeal on your own. Thousands of patients do, and many succeed. But it takes time, attention to detail, and a willingness to push back on a system that's designed to be discouraging. If you want to do it yourself, follow the steps above carefully and don't give up after the first no.

If you want help, there are resources available. Patient advocacy organizations for your specific condition often have appeal assistance programs. Your doctor's office may have staff who handle prior authorizations and appeals. And platforms like Appealio can help you organize your documentation, build your medical necessity argument, and navigate the appeal process step by step.

Need help organizing your Humira appeal? Appealio walks you through the process and helps you build a strong case.

Timeline: What to Expect

Here's a realistic timeline for the appeal process so you know what you're signing up for:

  • Days 1-7: Review your denial letter, request plan documents, and begin gathering medical records.
  • Days 7-14: Work with your doctor on the letter of medical necessity. Draft your appeal letter.
  • Day 14-21: Submit your internal appeal with all supporting documentation.
  • Days 21-51: Wait for the internal appeal decision. Insurers typically have 30 days for non-urgent claims, 72 hours for urgent/concurrent claims.
  • If denied: Request external review promptly. Standard external reviews are decided within 45 days; expedited reviews within 72 hours.

The total process can take anywhere from a few weeks to several months. If your condition is urgent, make sure your doctor notes that in the appeal and requests expedited review. You have the right to continue receiving treatment during the appeal if you were already on Humira and the denial is a coverage change.

Your Appeal Checklist

  • Read your denial letter carefully and identify the specific denial reason and code.
  • Request your plan's coverage criteria for Humira or biologics.
  • Gather medical records: diagnosis, treatment history, lab work, imaging, clinical notes.
  • Ask your doctor for a detailed letter of medical necessity that addresses the denial reason.
  • If step therapy was cited, document all previous medications tried, including dates, doses, and outcomes.
  • Check whether your state has a step therapy reform law that may entitle you to an exception.
  • Write a structured appeal letter referencing specific policy language and attaching all evidence.
  • Submit via certified mail and fax. Keep copies of everything.
  • Track deadlines and follow up if you don't hear back on time.
  • If your internal appeal is denied, request an external review before the deadline.

Disclaimer: This article is for educational and informational purposes only. It is not legal advice, medical advice, or a substitute for professional guidance. Every insurance plan and medical situation is different. Consult your physician about treatment decisions and consider speaking with a patient advocate or attorney about your specific appeal rights.

You Deserve the Treatment Your Doctor Prescribed

Getting a denial letter is demoralizing. It can feel like the system is stacked against you. And honestly? Parts of it are. But the appeals process exists for a reason, and it works more often than most people realize. Nearly half of internal appeals succeed. External reviews shift the decision to someone independent. The law is on your side.

Your doctor prescribed Humira because they believe it's the right treatment for you. A claims processor at an insurance company disagreed. You have every right to challenge that decision, and you should. Gather your evidence, write your letter, and file that appeal. The worst thing you can do is accept the denial without a fight.

You're not alone in this. Thousands of patients appeal medication denials every year, and many of them win. You can too.

humiraadalimumabbiologicsrheumatoid-arthritiscrohns-diseasepsoriatic-arthritisstep-therapy

Don't navigate the appeal process alone

Appealio generates professional, AI-powered appeal letters in minutes. $0 upfront. You only pay if your appeal succeeds.